Home » Topics » BioWorld Science

BioWorld Science
RSS

Surrozen advances research pipeline targeting Wnt pathway

Jan. 11, 2022

AC Immune synthesizes NLRP3 inflammasome inhibitors

Jan. 11, 2022

Researchers present new F-BODIPY dyes for cancer

Jan. 11, 2022

Sato Pharmaceutical patents new HPGDS inhibitors

Jan. 11, 2022

Century and Bristol Myers Squibb collaborate to develop iPSC-derived allogeneic cell therapies

Jan. 11, 2022

Autobahn Therapeutics discloses thyroid hormone receptor agonists

Jan. 11, 2022

InflaRx advances oral C5aR inhibitor INF-904 toward clinic

Jan. 11, 2022

Regulation of SWI/SNF complex SMARCA2/4 subunits for treating enhancer-addicted prostate cancer

Jan. 11, 2022

Researchers find novel PTSD-related biomarkers

Jan. 11, 2022

Immunization with MERS-CoV RNA replicons proves to be safe and effective in mice

Jan. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...